They’re having a big laugh at your expense while they rob you and the rest of the country blind.
seen from Malaysia
seen from Türkiye

seen from United States
seen from Saudi Arabia

seen from Maldives

seen from Germany

seen from United States

seen from Argentina
seen from China

seen from Germany
seen from United States
seen from Japan
seen from United States
seen from Germany

seen from Saudi Arabia
seen from Germany
seen from China
seen from China

seen from Poland
seen from United States
They’re having a big laugh at your expense while they rob you and the rest of the country blind.
https://www.nytimes.com/2025/09/22/well/leucovorin-autism-fda.html
I want to share some very valuable info (along with sources) to address what’s being said about leucovorin. I highly recommend following Dr. Jess Steier on Instagram/substack/etc
Outpatient prescriptions for the drug increased 71% after the announcement, but the FDA later approved it only for folate deficiency
https://www.wtfwire.com/health/leucovorin-autism-prescriptions-surge/
Leucovorin #autism prescriptions surge after White House promotion, leaving parents struggling to find the #drug at pharmacies.
Despite limited data, parents are rushing to find leucovorin for autism.
CHICAGO >> President Donald Trump’s adoption of an older generic drug called leucovorin for use in a rare disorder that causes autism-like symptoms has led to a surge in demand from parents who believe it can revitalize language skills and social connections in autistic children. That poses a challenge to pediatricians and experts, who warn that the science on leucovorin in autism is limited and…
The AAP does not recommend routine use of leucovorin in children with autism.
Highlights: The American Academy of Pediatrics (AAP) has issued new guidelines banning the routine use of leucovorin in children with autism, citing limited supporting evidence. The statement emphasizes shared decision-making, harm mitigation, and continued reliance on established autism treatments while research on leucovorin continues. The interim guidance follows the FDA’s plan to update…